Short answer
OCULAR THERAPEUTIX, INC (OCUL) filed an 8-K current report with the SEC on October 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Chief Strategy Officer Sanjay Nayak resigning effective October 16, 2026.
OCULAR THERAPEUTIX, INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Chief Strategy Officer Sanjay Nayak resigning effective October 16, 2026
- Departure to become CEO of a privately held company, indicating loss of senior strategic leadership
- No successor or transition arrangements identified in the filing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other OCULAR THERAPEUTIX, INC 8-K filings
Get the next OCUL 8-K as it lands
Follow OCUL for push alerts, or ask the research agent what this filing means.